SCHEMBL17909686

SCHEMBL17909686

CCCOC(=O)CCCOCCOCCOC

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.50
DNM1 Q05193 1/20 0.42
MAPT P10636 2/20 0.39
MAPK1 P28482 1/20 0.39
ALDH1A1 P00352 3/20 0.39
USP2 O75604 1/20 0.39
CYP3A4 P08684 2/20 0.38
ABCB11 O95342 1/20 0.38
ADRA2B P18089 1/20 0.38
OPRD1 P41143 1/20 0.38
SCN5A Q14524 1/20 0.38
EPHX2 P34913 2/20 0.38
PAM P19021 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
HTR2C P28335 1/20 0.38
MGLL Q99685 1/20 0.37
PRSS1 P07477 1/20 0.37
PRSS2 P07478 1/20 0.37
PRSS3 P35030 1/20 0.37
NAAA Q02083 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17909482 1.00 DGKA (0.50) DGKADNM1MAPTMAPK1ALDH1A1
SCHEMBL17908938 1.00 DGKA (0.50) DGKADNM1MAPTMAPK1ALDH1A1
SCHEMBL17908638 0.91 DGKA (0.53) DGKADNM1MAPTMAPK1ALDH1A1
SCHEMBL17909508 0.91 DGKA (0.53) DGKADNM1MAPTMAPK1ALDH1A1
SCHEMBL17909059 0.91 DGKA (0.53) DGKADNM1MAPTMAPK1ALDH1A1
SCHEMBL17908719 0.89 DGKA (0.56) DGKADNM1MAPTEPHX2PAM
SCHEMBL17908573 0.89 DGKA (0.56) DGKADNM1MAPTEPHX2PAM
SCHEMBL17908791 0.89 DGKA (0.56) DGKADNM1MAPTEPHX2PAM
SCHEMBL17908786 0.89 DGKA (0.59) DGKADNM1MAPTMAPK1ALDH1A1
SCHEMBL17908811 0.89 DGKA (0.59) DGKADNM1MAPTMAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3048093-B1 ETHER-CONTAINING MONOESTER COMPOUND AND USE THEREOF MORESCO CORP (JP) 2019-02-20 EP disclosed
US-10077229-B2 Ether-containing monoester compound and use thereof MORESCO CORPORATION (JP) 2018-09-18 US disclosed
EP-3048093-A1 ETHER-CONTAINING MONOESTER COMPOUND AND USE THEREOF Moresco Corporation (JP) 2016-07-27 EP disclosed
US-20160200998-A1 ETHER-CONTAINING MONOESTER COMPOUND AND USE THEREOF MORESCO CORPORATION (JP) 2016-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10077229-B2 Ether-containing monoester compound and use thereof SFN, CCNE2, HSD3B2 DGKA 1202/4885DNM1 1229/4885MAPT 3437/4885
US-20160200998-A1 ETHER-CONTAINING MONOESTER COMPOUND AND USE THEREOF SFN, CCNE2, MSMO1 DGKA 1333/4885DNM1 1142/4885MAPT 3717/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.